FMP-010 vaccine(Walter Reed Army Institute of Research)(FMP-010 vaccine(Walter Reed Army Institute of Research))

概要

基本信息

药物类型

治疗性疫苗、重组亚单位疫苗

别名

FMP 010 vaccine、FMP010/AS01B

靶点-

作用机制

免疫刺激剂

治疗领域

感染

在研适应症-

非在研适应症

疟疾恶性疟

原研机构

Walter Reed Army Institute of Research

在研机构-

非在研机构

GSK Plc

Kenya Medical Research Institute

Walter Reed Army Institute of Research

最高研发阶段终止临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

2

项与 FMP-010 vaccine(Walter Reed Army Institute of Research) 相关的临床试验

NCT00666380 / Completed临床1期

Phase 1a Open-label Dose Escalation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With GSK Biologicals' Adjuvant AS01B in Healthy Malaria-Naïve Adults

The purpose of this study is to determine whether an investigational malaria vaccine is safe and induces an immune response against malaria when tested in adults living in the United States.

开始日期2008-04-01

申办/合作机构

U S Army Medical Research & Development Command

[+3]

NCT02458092 / Completed临床1期

Phase 1b Controlled Double Blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With Glaxo Smith Kline (GSK) Biologicals' Adjuvant AS01B

The purpose of this study is to determine whether an investigational malaria vaccine is safe and induces an immune response against malaria when tested in adults living in the United States.

开始日期2008-04-01

申办/合作机构

U S Army Medical Research & Development Command

[+3]

100 项与 FMP-010 vaccine(Walter Reed Army Institute of Research) 相关的临床结果

登录后查看更多信息

100 项与 FMP-010 vaccine(Walter Reed Army Institute of Research) 相关的转化医学

登录后查看更多信息

100 项与 FMP-010 vaccine(Walter Reed Army Institute of Research) 相关的专利（医药）

登录后查看更多信息

100 项与 FMP-010 vaccine(Walter Reed Army Institute of Research) 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
恶性疟	临床1期	美国	Walter Reed Army Institute of Research	2008-04-01
恶性疟	临床1期	美国	GSK Plc	2008-04-01
恶性疟	临床1期	肯尼亚	Walter Reed Army Institute of Research	2008-04-01
恶性疟	临床1期	肯尼亚	GSK Plc	2008-04-01
疟疾	临床1期	-	GSK Plc	2008-04-01
疟疾	临床1期	-	Walter Reed Army Institute of Research	2008-04-01

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


NCT02458092 (CTgov)	临床1期	疟疾	30	Rabipur (Rabies Vaccine Rabipur)	顧製顧網鏇衊簾願獵鏇(鹹顧淵獵繭襯構壓艱積) = 廠鹹夢壓鏇獵膚襯鏇淵淵鬱構簾觸醖遞願壓網 (蓋積網網願齋廠餘廠夢, 繭艱壓齋壓築夢夢夢積 ~ 衊選顧蓋選製製鑰鹹窪) 更多	-	2020-06-09
				Plasmodium falciparum Malaria Protein 010 (FMP010) (50 µg of FMP010 Antigen in 0.5 mL AS01B Adjuvant)	窪膚鑰壓築築淵遞鬱襯(蓋窪鹽醖餘獵製糧膚選) = 夢網齋窪獵顧鹹廠窪窪鬱廠襯積簾襯夢鬱網繭 (遞遞遞鹽築鬱鏇壓蓋鹽, 製齋憲窪築鹽醖繭網齋 ~ 餘範廠範壓齋齋蓋淵獵) 更多